Mukka Proteins Limited (NSE: MUKKA) convened its board of directors on May 15, 2026, and submitted its financial results for the period ended March 31, 2026, to the National Stock Exchange, marking the close of its fiscal year 2025-26 reporting cycle.
Board Meeting Outcome
The company informed the exchange of two key outcomes from the board meeting held on May 15, 2026: the general outcome of the board deliberations and the formal submission of audited financial results for the quarter and full year ended March 31, 2026. No dividend declaration was announced alongside the results, and the company's dividend history on record currently shows no prior payouts, indicating that Mukka Proteins has not established a dividend track record since its listing.
Current Market Standing
At its last traded price of ₹23.85, Mukka Proteins carries a market capitalisation of approximately ₹715.5 Cr. The stock is trading at a price-to-earnings ratio of 14.94x, which is exactly in line with the sector PE of 14.94x, suggesting the market is currently pricing the stock at par with its peer group without any meaningful premium or discount on an earnings basis.
52-Week Price Context
The stock's 52-week range highlights notable price compression over the past year. MUKKA touched a 52-week high of ₹32.80 on June 10, 2025, and subsequently fell to a 52-week low of ₹18.27 on March 30, 2026, representing a peak-to-trough decline of approximately 44.3%. At the current price of ₹23.85, the stock sits roughly 27.3% below its 52-week high and approximately 30.5% above its 52-week low, placing it in the lower half of its annual trading range.
Trading Activity and Delivery Data
On the date of the board meeting announcement, MUKKA recorded a trading volume of 1,76,553 shares, with a delivery percentage of 65.41%. A delivery percentage above 60% is generally considered indicative of meaningful buying interest rather than purely intraday or speculative activity, suggesting that a significant portion of participants on this session intended to hold their positions. Daily volatility stands at 2.25%, reflecting moderate price movement risk on a session-to-session basis.
Company Background
Mukka Proteins Limited is engaged in the manufacture and sale of fish meal, fish oil, and related marine protein products, primarily serving the aquaculture and animal feed industries. The company operates in a sector closely tied to raw material availability from marine catch cycles and export demand dynamics, particularly from Southeast Asian and Middle Eastern markets.
What This Means for Investors
- The absence of any dividend announcement alongside Q4 FY26 results means there is no yield income event for existing shareholders at this stage.
- With no dividend history on record, income-focused investors should note that Mukka Proteins does not currently offer a dividend yield at any price point.
- The stock's valuation at sector-average PE of 14.94x leaves limited room for valuation-driven re-rating without a meaningful earnings upgrade.
- The delivery percentage of 65.41% on the results date suggests that institutional or positional interest remains present despite the stock trading well below its one-year peak.
Investors tracking MUKKA should await the detailed financial results disclosure, including revenue, EBITDA margins, and net profit figures for FY26, to assess the earnings trajectory before drawing conclusions on valuation adequacy at current levels.